ArticleBiosynthesis of Butirosin (cas 12772-35-9): Transfer and Deprotection of the Unique Amino Acid Side Chain

Add time:08/28/2019    Source:sciencedirect.com

SummaryButirosin, an aminoglycoside antibiotic produced by Bacillus circulans, bears the unique (S)-4-amino-2-hydroxybutyrate (AHBA) side chain, which protects the antibiotic from several common resistance mechanisms. The AHBA side chain is advantageously incorporated into clinically valuable antibiotics such as amikacin and arbekacin by synthetic methods. Therefore, it is of significant interest to explore the biosynthetic origins of this useful moiety. We report here that the AHBA side chain of butirosin is transferred from the acyl carrier protein (ACP) BtrI to the parent aminoglycoside ribostamycin as a γ-glutamylated dipeptide by the ACP:aminoglycoside acyltransferase BtrH. The protective γ-glutamyl group is then cleaved by BtrG via an uncommon γ-glutamyl cyclotransferase mechanism. The application of this pathway to the in vitro enzymatic production of novel AHBA-bearing aminoglycosides is explored with encouraging implications for the preparation of unnatural antibiotics via directed biosynthesis.

We also recommend Trading Suppliers and Manufacturers of Butirosin (cas 12772-35-9). Pls Click Website Link as below: cas 12772-35-9 suppliers

Prev:Unique O-ribosylation in the biosynthesis of Butirosin (cas 12772-35-9)
Next:Regular paperThe complete 1H NMR assignments of aminoglycoside antibiotics and conformational studies of Butirosin (cas 12772-35-9) A through the use of 2D NMR spectroscopy)